Collegium Pharmaceutical (COLL) Acquisitions (2018 - 2022)
Collegium Pharmaceutical (COLL) posted quarterly Acquisitions of $572.1 million for Q1 2022, up 493062.93% quarter-over-quarter from $116000.0 in Q2 2018.
Collegium Pharmaceutical (COLL) Acquisitions (2018 - 2022) Analysis & Trends
Collegium Pharmaceutical's Acquisitions history runs 2 years deep, the most recent figure standing at $572.1 million for Q1 2022.
- In Q1 2022, Acquisitions changed N/A year-over-year to $572.1 million; the TTM figure through Dec 2022 stood at $572.1 million (changed N/A YoY), while the FY2024 annual figure was $267.5 million, changed N/A from the prior year.
- Acquisitions for Q1 2022 stood at $572.1 million, up from $116000.0 in the prior quarter.
- The five-year high for Acquisitions was $572.1 million in Q1 2022, with the low at $116000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Collegium Pharmaceutical | 889.49 Mn | 740.17 Mn | 110.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 572.07 Mn |
| Jun 30, 2018 | 116,000.00 |
| Mar 31, 2018 | 18.76 Mn |